Medicover AB Series BMedicover is selling its 66.9% stake in its Indian hospital business to KKR for at least $1.05 billion, a significant divestiture.
KKR has entered advanced talks to acquire Sweden-based Medicover's 66.9% stake in its Indian hospital business for at least US$1.05 billion. The firm also reported quarter-to-date monetization income above US$900 million, mostly from realized performance fees. Starting in the second quarter of 2026, KKR will align its reporting of realized performance fees with industry practice, a shift that may help investors better assess the quality and sustainability of its earnings.
Medicover AB Series BMedicover is selling its 66.9% stake in its Indian hospital business to KKR for at least $1.05 billion, a significant divestiture.
KKR & Co. Inc.KKR is in advanced talks to acquire a 66.9% stake in Medicover's India hospital business for at least $1.05 billion, and reported over $900 million in quarter-to-date monetization income.